Pharmaceutical Corruption Media Articles

Excerpts of Key Pharmaceutical Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on pharmaceutical industry corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

More than 30 of the most common antidepressants used in the UK are to be reviewed by the UK's medicines regulator, as figures point to hundreds of deaths linked to suicide and self-harm among people prescribed these drugs. The medicines, which include Prozac and are prescribed to millions of patients, will all be looked at by the Medicines and Healthcare products Regulatory Agency (MHRA). It follows concerns raised by families in Britain over the adequacy of safety measures in place to protect those taking the drugs, such as warnings about potential side effects. There has been a huge rise in the use of antidepressants in England, with 85 million prescriptions issued in 2022-23, up from 58 million in 2015-16, according to NHS figures. Nigel Crisp, a crossbench peer and chair of the Beyond Pills all-party parliamentary group, [said]: "Overprescribing of antidepressants has an enormous cost in terms of human suffering, because so many people become dependent and then struggle to get off them – and it wastes vital NHS resources." More than 515 death alerts linked to these drugs, involving suicidal ideation and self-harm, have been made to the MHRA since the year 2000. Some antidepressants have been given to children as young as four, and the total cost of the medication to the NHS in 2022-23 was more than Ł231m. Side effects of many antidepressants can include suicidal thoughts and anxiety, according to the National Institute for Health and Care Excellence.

Note: A UK coroner has issued a warning about the effects of antidepressants and how their use could lead to more deaths without a change in guidance and labeling about the risks. For more along these lines, read our concise summaries of news articles on mental health and Big Pharma corruption.

Pfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn patients about possible cancer risks caused by the anti-heartburn medication Zantac. The lawsuits were filed in state courts across the country, but the agreements don't completely resolve Pfizer's exposure to the claims linking Zantac and cancer. Zantac was brought to market in 1983 by Glaxo Holdings, a company that is now part of the GlaxoSmithKline company. By 1988, it was the world's best selling drug as patients reported benefits for conditions such as heartburn, ulcers and acid reflux. In 2020, the Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in samples of the drug. Thousands of lawsuits began piling up in federal and state courts against Pfizer, GSK, Sanofi and Boehringer Ingelheim. Last month, Sanofi reached an agreement in principle to settle 4,000 lawsuits linking Zantac to cancer. Sanofi did not disclose the financial terms of the deal, but Bloomberg News reported that the company will pay $100 million – or $25,000 to each plaintiff. Sanofi still faces about 20,000 lawsuits over Zantac in Delaware state court. A judge in Delaware Superior Court in Wilmington is weighing the fate of about 70,000 cases filed against Sanofi and other defendants, including GSK, Pfizer and Boehringer Ingelheim.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

One ALS drug made $400 million in sales for its maker. It doesn't work. A cancer treatment brought in $500 million. That one turned out to have no effect on survival. A blood cancer medication made nearly $850 million before being withdrawn for two of its uses. That drug had been linked to patient deaths years prior. All of them were allowed to be sold to Americans because of the US Food and Drug Administration's drive to get new drugs to patients quickly – sometimes even before they're done testing. Drug companies are profiting, though. Since 2014, they've made at least $3.6 billion in global sales of medications that have either later been shown to be ineffective or had most or all of their uses withdrawn in the US. There are a number of ways a drug company can get its treatment to patients faster: There's the "priority review" pathway, then "fast track," "accelerated approval" and "breakthrough therapy." The majority of new drugs in the US are approved through one or more of these sped-up pathways. Last year two thirds of all new drugs reached the market this way. One of the problems is that sometimes drugmakers resist pulling a drug off the market, even after it's obvious it doesn't work. Makena, a drug to reduce the risk of premature birth, received a sped-up approval in 2011. Eight years later, a large trial found it didn't work. Yet it took another four years for the FDA to force it off the market. Makena ... generated over $1.6 billion in sales.

Note: The US spends the most on health care but has the worst health outcomes among high-income countries. More than half of children now have chronic health conditions. What is behind this? For more along these lines, see concise summaries of important news articles on Big Pharma corruption and health from reliable media sources.

Almost six in ten doctors in the US received more than $12 billion in payments from pharma firms in the past decade, an analysis has revealed. A study by researchers at Yale University found that 57 percent of doctors earned the huge sums from manufacturers in relation to medical drugs or devices between 2013 and 2022. Most of the money was for consulting services or fees for things such as serving as a speaker at a venue, but the physicians also received large amounts of money for food and beverages and gifts. Orthopedic surgeons were found to receive the largest total sum of payments, at $1.36bn, and the most common drugs related to payments were blood thinners Xarelto and Eliquis. 'Despite evidence that financial conflicts of interest may influence physician prescribing and may damage patients' trust in medical professionals, such payments remain pervasive,' the researchers wrote. After orthopedic surgeons, the physicians that received the largest total sum of payments were neurologists and psychiatrists, who received $1.32bn, and cardiologists, who got $1.29bn. Although the median payment to doctors was $48, payments to the top 0.1 percent of doctors were far higher and differed depending on specialty. The average amount paid to the top 0.1 percent of orthopedists was $4,826,944. For the top 0.1 percent of cardiologists, it was $3,197,675, and for the top 0.1 percent of neurologists and psychiatrists it was $2,588,819.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

An advertising agency that helped market the blockbuster painkiller OxyContin will pay $350 million to states ravaged by the nation's opioid crisis. Attorneys general from multiple states alleged that Publicis Health developed "unfair and deceptive" marketing campaigns aimed at persuading doctors to prescribe the addictive drug for longer periods of time and at higher doses. The company's client was Purdue Pharma, the Connecticut drugmaker accused in lawsuits of helping ignite the epidemic through aggressive marketing and sales of OxyContin. Publicis, a subsidiary of French ad giant Publicis Groupe, settled with 50 states and D.C. Under the agreements, Publicis Health will stop accepting work related to prescription opioids and must release thousands of internal documents chronicling its dealings with companies such as Purdue. It is the first settlement with an advertising agency connected to the opioid crisis, according to the New York attorney general's office. "Publicis was responsible for creating advertisements and materials, such as pamphlets and brochures that promoted OxyContin as safe and unable to be abused, even though this claim was not true," according to a news release from the office of New York Attorney General Letitia James. Drug overdoses killed nearly 110,000 people in the United States in 2022, a record high, according to federal death statistics.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Justice Department investigators are scrutinizing the healthcare industry's use of AI embedded in patient records that prompts doctors to recommend treatments. Prosecutors have started subpoenaing pharmaceuticals and digital health companies to learn more about generative technology's role in facilitating anti-kickback and false claims violations, said three sources familiar with the matter.. Two of the sources–speaking anonymously to discuss ongoing investigations–said DOJ attorneys are asking general questions suggesting they still may be formulating a strategy. "I have seen" civil investigative demands "that ask questions about algorithms and prompts that are being built into EMR systems that may be resulting in care that is either in excess of what would have otherwise been rendered, or may be medically unnecessary," said Jaime Jones, who co-leads the healthcare practice at Sidley Austin. DOJ attorneys want "to see what the result is of those tools being built into the system." The probes bring fresh relevance to a pair of 2020 criminal settlements with Purdue Pharma and its digital records contractor, Practice Fusion, over their collusion to design automated pop-up alerts pushing doctors to prescribe addictive painkillers. The kickback scheme ... led to a $145 million penalty for Practice Fusion. Marketers from Purdue ... worked in tandem with Practice Fusion to build clinical decision alerts relying on algorithms.

Note: Read how the US opioid industry operated like a drug cartel. For more along these lines, see concise summaries of deeply revealing news articles on AI and Big Pharma corruption from reliable major media sources.

Researchers have long known that any single antidepressant drug is little more effective than a placebo in the majority of trials, shown to be less effective than a placebo in some studies, and generally found to be "clinically negligible" with respect to depression remission, while often resulting in severe adverse effects; for example, resulting in a higher percentage of sexual dysfunction than depression remission. However, for nearly twenty years, psychiatry and Big Pharma have told us that while one antidepressant may not work for the majority of patients, in the "real world," doctors provide patients who have been failed by their initial antidepressant with another antidepressant, and if that fails, still another; and that this real-world treatment is successful for nearly 70% of patients. The problem with this "nearly 70%" story is that the research that has been used to justify it, a 2006 report on the results of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D), has long been disputed by researchers. Moreover, a recent reanalysis of previously undisclosed data reveals that STAR*D, owing to scientific misconduct that dramatically inflated remission rates, may go down in US medical history as one of its most harmful scandals. Even [STAR*D's] fabricated 67% depression remission rate should never have been celebrated. 85% of depressed individuals who go without somatic treatments spontaneously recover within 1 year.

Note: Read more important news articles we've summarized on medical and scientific corruption regarding antidepressants. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Sixty percent of US physicians serving as panel and task force members for the American Psychiatric Association's official manual of psychiatric disorders received payments from industry totalling $14.24m, finds a study published by The BMJ. Because of the enormous influence of diagnostic and treatment guidelines, the researchers say their findings "raise questions about the editorial independence of this diagnostic manual." Often referred to as the ‘bible' of psychiatric disorders, the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, text revision (DSM-5-TR) is the latest edition of the guide that doctors use to diagnose and treat patients. It is thus critical that authors of this psychiatric taxonomy should be free of industry ties. But until the development of Open Payments ... it wasn't possible to determine the amount of monies received by authors of diagnostic and clinical practice guidelines. Their analysis included 92 physicians based in the US who served as members of either a panel (86) or task force (6) on the DSM-5-TR from 2016-19. Of these 92 individuals, 55 (60%) received payments from industry. Collectively, these panel members received a total of $14.24m (Ł11.21m; â‚Ź12.96m). The most common types of payment were for food and beverages (91%), followed by travel (69%) and consulting (69%). The greatest proportion of compensation by category of payment was for research funding (70%). To ensure unbiased, evidence based mental health practice, there should be a rebuttable presumption of prohibiting financial conflicts of interest among the panel and task force members.

Note: A recent study found that 80% of the global population will be treated for mental illness at some point in their lives, and that their lives are worse in many ways after receiving diagnosis and treatment. For more along these lines, see concise summaries of deeply revealing news articles on health and Big Pharma profiteering from reliable major media sources.

Victims who suffered life-changing injuries from the Oxford-AstraZeneca Covid vaccine say they have faced censorship on social media when trying to discuss their symptoms. The UK-based pharmaceutical giant is being sued in the High Court in a test case by a father-of-two who suffered a significant permanent brain injury as a result of a blood clot after receiving the jab in spring 2021. A second claim is also being brought by the widower and two young children of a woman who died after having the jab. Some who have experienced serious adverse reactions from the AstraZeneca vaccine ... have been given "warnings" on social media websites such as Facebook when trying to talk to one another about their experiences. They say they are being forced to "self censor" and speak in code to avoid having their support groups shut down. In one instance, YouTube attempted to censor a video of testimony given by lawyers to the Covid Inquiry about vaccines, flagging the clip as a violation of its "medical misinformation policy". UK CV Family, a private Facebook group with 1.2k members for people left injured or bereaved from Covid vaccines, was started in November 2021 by Charlet Crichton after she suffered an adverse reaction from the AstraZeneca jab. Facebook blocked Ms Crichton from commenting at one stage "to prevent misuse" and there were occasions where her account was temporarily banned because her "activity didn't follow our community standards".

Note: For more along these lines, see concise summaries of deeply revealing news articles on government COVID vaccines and media manipulation from reliable sources.

Sidney M. Wolfe, an American physician turned activist who relentlessly lobbied against drug companies and the US Food and Drug Administration, died on Monday in his Washington home. He was 86. Wolfe ... co-founded the Public Citizen's Health Research Group, which "promotes research-based, system-wide changes in health-care policy and drug safety," according to the group's website. He also served as the director and senior adviser of the non-profit, where he crusaded against FDA rulings on more than two dozen dangerous or ineffective drugs until they were yanked off the market. In an op-ed published in HuffPost in 2011, Wolfe ridiculed the FDA for being "cautious on food safety – reckless on prescription drug safety." The banned medicines include the diabetes drug phenformin, which was linked to hundreds of deaths and sold under the trade names DBI and Meltrol in the US for 20 years. Wolfe was also responsible for the banning of the anti-inflammatory Vioxx ... which he warned caused serious heart damage years before it was taken off the market – as well as the anti-diarrheal alosetron. His group also successfully petitioned federal regulators to include a warning on aspirin bottles about Reye's syndrome, a rare but potentially fatal condition that causes swelling in the liver and brain. In addition, Wolfe was a fierce foe of silicone gel-filled breast implants for breast augmentation and reconstruction surgeries, claiming in the 1980s that they cause cancer.

Note: Read the full remembrance of Dr. Sidney Wolfe's legacy. His leadership helped remove 28 dangerous medications off the market, and paved the way for "vital and path-breaking research and advocacy on doctor discipline, mental health, tobacco, pharmaceutical marketing, drug company payments to doctors, medical devices, health insurance and the imperative of Medicare for All, unnecessary Cesarean sections, unregulated supplements, medical resident work hours, and more." For more along these lines, see concise summaries of deeply revealing news articles on health and Big Pharma corruption from reliable major media sources.

Poison control centers across the US say they are seeing a steep increase in calls related to semaglutide, an injected medication used for diabetes and weight loss, with some people reporting symptoms related to accidental overdoses. Some have even needed to be hospitalized for severe nausea, vomiting and stomach pain, but their cases seem to have resolved after they were given intravenous fluids and medications to control nausea. From January through November, the America's Poison Centers reports nearly 3,000 calls involving semaglutide, an increase of more than 15-fold since 2019. In 94% of calls, this medication was the only substance reported. In most of the calls, people reported dosing errors, said Dr. Kait Brown, clinical managing director of the association. "Oftentimes, it's a person who maybe accidentally took a double dose or took the wrong dose," Brown said. Semaglutide was approved by the US Food and Drug Administration in 2017. It is sold as Ozempic when used for diabetes and Wegovy when used for weight loss. Even when used as directed by a doctor, people can have stomach and bowel side effects, including nausea, vomiting and constipation, especially when they start the drugs. After celebrities began openly embracing Ozempic on social media in 2022 as a way to lose weight, demand overwhelmed supply. There's no specific antidote for a semaglutide overdose.

Note: The money behind the makers of weight-loss drugs is staggering, with the economic value of Wegovy's Novo Nordisk soaring to over $420 billionexceeding the entire GDP of Denmark, its home country. Read more on the significant adverse effects associated with these drugs. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

If you've ever found yourself absentmindedly humming the "oh-oh-oh-Ozempic" jingle, you have David Paton to blame. The singer-songwriter ... co-wrote "Magic" – the 1975 hit for his band Pilot that he reworked and sang for the trendy weight-loss drug's TV commercials, which play incessantly. "I have heard from doctors about patients not remembering the names of drugs but singing the songs," a former product manager for drug companies that include Merck and Pfizer, [said]. It can cost billions of dollars to develop a pharmaceutical, so promoting it is essential. And that all starts with the name. "We try to craft a name that [has] five to nine letters and two to four syllables." But it even comes down to the exact letters. "Let's say there is an oral drug instead of an injectable, we'll explore something that sounds liquidy or has an O in it," Fernando Fernandez, managing director of BX: Brand Experience Design Group, [said]. "If we expect a product to have an extra level of efficacy, we might put an X in the name." Consumers like taking drugs with the letter Z, which may have played a role in the naming of Ozempic and Zepbound. According to the Canadian Medical Journal, the letters X, Y and Z all impart a "high tech, sciency" [sic] feeling to drugs such as the sleeping medication Xanax. "People have hesitancy about taking drugs," a medical advertising veteran told The Post. "If they don't have diabetes, they wonder why they are taking a diabetes drug to lose weight. The weight-loss drug has to be called something different, even though it is very close to being the same thing. The name Wegovy is playful and memorable and obviously works."

Note: The money behind the makers of weight-loss drugs is staggering, while concerns grow about the significant adverse effects of these drugs. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.

The nation's largest pharmacy chains have handed over Americans' prescription records to police and government investigators without a warrant, a congressional investigation found, raising concerns about threats to medical privacy. Though some of the chains require their lawyers to review law enforcement requests, three of the largest – CVS Health, Kroger and Rite Aid, with a combined 60,000 locations nationwide – said they allow pharmacy staff members to hand over customers' medical records in the store. Pharmacies' records hold some of the most intimate details of their customers' personal lives, including years-old medical conditions and the prescriptions they take for mental health and birth control. Because the chains often share records across all locations, a pharmacy in one state can access a person's medical history from states with more-restrictive laws. The Health Insurance Portability and Accountability Act, or HIPAA, regulates how health information is used and exchanged among "covered entities" such as hospitals and doctor's offices. But the law gives pharmacies leeway as to what legal standard they require before disclosing medical records to law enforcement. In briefings, officials with eight American pharmacy giants – Walgreens Boots Alliance, CVS, Walmart, Rite Aid, Kroger, Cigna, Optum Rx and Amazon Pharmacy – told congressional investigators that they required only a subpoena, not a warrant, to share the records.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the disappearance of privacy from reliable major media sources.

A New Zealand man was recently arrested after allegedly illegally accessing COVID-19 vaccine data from the country's health agency. Barry Young, 56, a former IT employee at Te Whatu Ora, the country's health agency, was arrested and accused of illegally obtaining COVID-19 vaccine data and sharing it on the internet. Young appeared on Infowars, where he was interviewed by ... Alex Jones. "I just looked at the data and what I was seeing, since the rollout, it just blew my mind. I was just seeing more and more people dying that shouldn't have been dying. It was just obvious," Young told Jones. The incident comes as COVID-19 vaccine skeptics have continued to question the efficacy of the inoculation. Texas Attorney General Ken Paxton recently announced that he was suing vaccine manufacturer Pfizer "for unlawfully misrepresenting the effectiveness of the company's COVID-19 vaccine and attempting to censor public discussion of the product." During the interview with Infowars, Young explained that he had suspicions about the COVID-19 vaccine in New Zealand since its rollout. "I want people to analyze this, I want people to look at it...we need to open it up and the government needs to have an inquiry about it. Just bring it to the public's attention," Young said.

Note: U.S.-based genomics scientist Kevin McKernan had uploaded Barry Young's data onto a file hosting service, MEGA, only to have his whole account deleted by MEGA overnight. For more along these lines, see concise summaries of deeply revealing news articles on COVID vaccine problems from reliable major media sources.

Medical experts and politicians have called for the amount of antidepressants being prescribed to people across the UK to be reduced in an open letter to the government. The letter coincides with the launch of the all-party parliamentary group Beyond Pills, which aims to reduce what it calls the UK healthcare system's over-reliance on prescription medication. A total of 8.6 million patients in England were prescribed antidepressants in 2022-23, with the amount having almost doubled since 2011. Published in the British Medical Journal ... the letter says: "Rising antidepressant prescribing is not associated with an improvement in mental health outcomes at the population level, which, according to some measures, have worsened as antidepressant prescribing has risen." The letter goes on to say that reducing the rate of antidepressant prescriptions could be achieved through measures that includes stopping the prescribing of antidepressants for mild conditions, and funding and delivering a national 24-hour prescribed drug withdrawal helpline ... to help those experiencing withdrawal symptoms from prescription medication. [Former chief executive of NHS England, Nigel] Crisp said: "The high rate of prescribing of antidepressants over recent years is a clear example of over-medicalisation, where patients are often prescribed unnecessary and potentially harmful drugs instead of tackling the root causes of their suffering, such as loneliness, poverty or poor housing.

Note: Antidepressants are some of the most commonly prescribed medications, yet their significant risks are often withheld from public debate. For more along these lines, see concise summaries of deeply revealing news articles on health and Big Pharma corruption from reliable major media sources.

In 2010, Purdue Pharma replaced the original version of OxyContin, an extended-release oxycodone pill, with a reformulated product that was much harder to crush for snorting or injection. The reformulation of OxyContin was instead associated with an increase in deaths involving illicit opioids and, ultimately, an overall increase in fatal drug overdoses. Researchers ... found that death rates rose fastest in states where reformulation would have had the biggest impact. A new study by RAND Corporation senior economist David Powell extends those findings by showing that the reformulation of OxyContin also was associated with rising suicides among children and teenagers. The root cause of such perverse effects was the substitution that occurred after the old version of OxyContin was retired. Nonmedical users turned to black-market alternatives that were more dangerous because their potency was highly variable and unpredictable–a hazard that was compounded by the emergence of illicit fentanyl as a heroin booster and substitute. The fallout from the reformulation of OxyContin is one example of a broader tendency: Interventions aimed at reducing the harm caused by substance abuse frequently have the opposite effect. Based on interstate differences in nonmedical use of OxyContin prior to 2010, Powell estimates that "the reformulation of OxyContin can explain 49% of the rise in child suicides."

Note: More than 107,000 people in the United States died due to opioid overdoses in 2021. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs [Wegovy and Saxenda], a Reuters analysis found. It concentrated that money on an elite group of obesity specialists who advocate giving its powerful and expensive drugs to tens of millions of Americans. Those payments are part of a campaign to convince U.S. doctors to make Wegovy one of the most widely prescribed drugs in history – and to persuade skeptical insurers to pay for it. Overall, at least 57 U.S. physicians each accepted at least $100,000 from Novo in payments associated with Wegovy or Saxenda. They were an influential group: Forty-one were obesity specialists who run weight-management clinics, work at academic hospitals, write obesity-treatment guidelines or hold top positions at medical societies, according to a Reuters review. "As sales grow, Medicare and the insurance industry come under intense pressure to pay for these hugely expensive drugs," [Former dean of the US military's medical school Dr. Arthur] Kellermann said. "The end result is that everybody's healthcare costs go up." U.S. and European regulators are studying whether GLP-1 drugs can cause suicidal thoughts. Reuters reported in September that at least 265 reports have been filed with the FDA since 2010 describing suicidal ideation or behavior in patients taking these drugs. Thirty-six reports described a death by suicide or suspected suicide.

Note: The money behind these obesity drug makers is staggering. The economic value of Novo Nordisk soared to over $420 billion, which exceeds the entire GDP of Denmark, its home country. As Lee Fang reports in this investigative piece on the issue, "The company is growing so fast, bringing in so many American dollars, that the Danish central bank recently devalued its currency to keep it in line with the euro." For more along these lines, read the growing reports of concerning adverse side effects from these weight-loss drugs.

The Moderna misinformation reports, reported here for the first time, reveal what the pharmaceutical company is willing to do to shape public discourse around its marquee product. The mRNA COVID-19 vaccine catapulted the company to a $100 billion valuation. Behind the scenes, the marketing arm of the company has been working with former law enforcement officials and public health officials to monitor and influence vaccine policy. Key to this is a drug industry-funded NGO called Public Good Projects. PGP works closely with social media platforms, government agencies and news websites to confront the "root cause of vaccine hesitancy" by rapidly identifying and "shutting down misinformation." A network of 45,000 healthcare professionals are given talking points "and advice on how to respond when vaccine misinformation goes mainstream", according to an email from Moderna. An official training programme, developed by Moderna and PGP, alongside the American Board of Internal Medicine, [helps] healthcare workers identify medical misinformation. The online course, called the "Infodemic Training Program", represents an official partnership between biopharma and the NGO world. Meanwhile, Moderna also retains Talkwalker which uses its "Blue Silk" artificial intelligence to monitor vaccine-related conversations across 150 million websites in nearly 200 countries. Claims are automatically deemed "misinformation" if they encourage vaccine hesitancy. As the pandemic abates, Moderna is, if anything, ratcheting up its surveillance operation.

Note: Strategies to silence and censor those who challenge mainstream narratives enable COVID vaccine pharmaceutical giants to downplay the significant, emerging health risks associated with the COVID shots. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and the disappearance of privacy from reliable major media sources.

The U.S. was in a fit of Covid panic during Thanksgiving week two years ago. By month's end, Pfizer's stock-market value had surpassed $300 billion, up 50% from the start of the pandemic. Moderna's shares had soared by more than 1,000% over the same period. In 2022 Pfizer became the first pharmaceutical company to book more than $100 billion in annual sales owing to government purchases of its vaccines and antiviral pill. Fast-forward to today. The pandemic is over. Demand for Covid vaccines and treatments has plunged. Pfizer's total revenue has fallen more than 40% since last year. Earlier this month the company took a $5.5 billion write-off on its Covid products owing to "lower-than-expected demand." Only 14% of American adults have received the latest updated booster shots. The jabs' greatest benefit was in providing political leaders with the courage to lift destructive lockdowns and mask mandates. The vaccines were supposed to be a two-shot-and-done regimen, not blockbuster medicines that rung up tens of billions of dollars in sales every year with government support. Statins and diabetes medicines prevent heart attacks, but the government doesn't run ads urging Americans to use Lipitor or Ozempic. The government's vaccine boosterism ... has increased public cynicism toward pharmaceutical companies. Drug makers can dine out on any given medicine only for so long before needing to cook up another pharmaceutical bonanza.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering and coronavirus vaccines from reliable major media sources.

The Oxford-AstraZeneca Covid-19 vaccine has been branded "defective" in a multi-million pound landmark legal action that will suggest claims over its efficacy were "vastly overstated". The pharmaceutical giant is being sued in the High Court in a test case by Jamie Scott, a father-of-two who suffered a significant permanent brain injury that has left him unable to work as a result of a blood clot after receiving the jab in April 2021. A second claim is being brought by the widower and two young children of 35-year-old Alpa Tailor, who died after having the jab made by AstraZeneca. The test cases could pave the way for as many as 80 damages claims worth an estimated Ł80 million over a new condition known as Vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT) that was identified by specialists in the wake of the AstraZeneca Covid-19 vaccine rollout. In the months following the rollout, the potential serious side effect of the AstraZeneca jab was identified by scientists. Following this, it was recommended it no longer be given to the under-40s in the UK because the risk of receiving the jab outweighed the harm posed by Covid. Official figures ... show at least 81 deaths in the UK are suspected to have been linked to the adverse reaction that caused clotting in people who also had low blood platelets. Victims and their lawyers question the Government's monitoring of the rollout and point out that ... Germany suspended the vaccine's use for the under 60s at the end of March 2021.

Note: In the US, when current and former FDA advisers and academics asked the FDA to improve COVID vaccine labeling given the risk of severe vaccine injuries, the agency denied almost every single request. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.